Vor Biopharma Inc (VOR)
1.755
-0.02
(-0.85%)
USD |
NASDAQ |
May 02, 16:00
1.755
0.00 (0.00%)
After-Hours: 18:38
Vor Biopharma 1 Year Total Returns (Daily): -58.74% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -58.74% |
April 30, 2024 | -61.35% |
April 29, 2024 | -60.90% |
April 26, 2024 | -62.02% |
April 25, 2024 | -60.56% |
April 24, 2024 | -62.09% |
April 23, 2024 | -59.40% |
April 22, 2024 | -60.69% |
April 19, 2024 | -59.76% |
April 18, 2024 | -61.47% |
April 17, 2024 | -63.42% |
April 16, 2024 | -63.77% |
April 15, 2024 | -61.86% |
April 12, 2024 | -60.50% |
April 11, 2024 | -59.20% |
April 10, 2024 | -61.60% |
April 09, 2024 | -59.42% |
April 08, 2024 | -57.48% |
April 05, 2024 | -57.65% |
April 04, 2024 | -60.31% |
April 03, 2024 | -59.85% |
April 02, 2024 | -61.15% |
April 01, 2024 | -59.11% |
March 28, 2024 | -56.83% |
March 27, 2024 | -60.68% |
Date | Value |
---|---|
March 26, 2024 | -63.27% |
March 25, 2024 | -65.31% |
March 22, 2024 | -64.46% |
March 21, 2024 | -64.81% |
March 20, 2024 | -65.45% |
March 19, 2024 | -64.59% |
March 18, 2024 | -62.65% |
March 15, 2024 | -61.71% |
March 14, 2024 | -63.75% |
March 13, 2024 | -57.32% |
March 12, 2024 | -57.05% |
March 11, 2024 | -55.13% |
March 08, 2024 | -57.06% |
March 07, 2024 | -59.45% |
March 06, 2024 | -59.08% |
March 05, 2024 | -58.13% |
March 04, 2024 | -56.02% |
March 01, 2024 | -58.80% |
February 29, 2024 | -58.78% |
February 28, 2024 | -61.29% |
February 27, 2024 | -63.22% |
February 26, 2024 | -66.41% |
February 23, 2024 | -68.52% |
February 22, 2024 | -65.98% |
February 21, 2024 | -64.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.99%
Minimum
Mar 31 2022
23.14%
Maximum
May 26 2023
-54.15%
Average
-59.42%
Median
Apr 09 2024
1 Year Total Returns (Daily) Benchmarks
Masimo Corp | -29.14% |
AnaptysBio Inc | 22.77% |
Apellis Pharmaceuticals Inc | -44.49% |
NovaBay Pharmaceuticals Inc | -91.85% |
Palatin Technologies Inc | -18.34% |